Hesperetin, a major
bioflavonoid in sweet oranges and lemons, has been reported to have anti-inflammatory properties. However, the effect of
hesperetin on
ventilator-induced
acute lung injury has not been studied. In present study, we investigated the protective effect of
hesperetin on
ventilator-induced
acute lung injury in rats. Rats were orally administered
hesperetin (10, 20, or 40mg/kg) two hour before
acute lung injury was induced by
mechanical ventilation. Rats were then randomly divided into six groups: the lung protective ventilation group (n=20, LV group), injurious ventilation group (n=20, HV group), vehicle-treated injurious ventilation group (n=20, LV+vehicle group),
hesperetin (10mg/kg)-treated
acute lung injury group (n=20, HV+Hsp (10mg)),
hesperetin (20mg/kg)-treated
acute lung injury group (n=20, HV+Hsp (20mg)), and
hesperetin (40mg/kg)-treated
acute lung injury group (n=20, HV+Hsp (40mg)). The lung tissues and bronchoalveolar lavage fluid were isolated for subsequent measurements. Treatment with
hesperetin dramatically improved the histology of lung tissue, and reduced the wet/dry ratio,
myeloperoxidase activity,
protein concentration, and production of
tumor necrosis factor (TNF)-α,
interleukin (IL)-6, IL-1β, and MIP-2 in the bronchoalveolar lavage fluid of rats with
ventilator-induced
acute lung injury. Additionally, our study indicated that this protective effect of
hesperetin results from its ability to increase the expression of
peroxisome proliferator-activated receptor (
PPAR)-γ and inhibit the activation of the nuclear factor (NF)-κB pathway. These results suggest that
hesperetin may be a potential novel therapeutic candidate for protection against
ventilator-induced
acute lung injury.